2025-03572Notice

Drug Office Names New Exec Performance Review Board Members

Published Date: 3/6/2025

Notice

Summary

The Office of National Drug Control Policy just named four new members to their Senior Executive Service Performance Review Board, with Ms. Martha Gagné leading as Chair. These folks will help review top executives’ performance, making sure the agency runs smoothly and effectively. This update affects senior leaders and keeps the agency on track, with no direct money changes or deadlines announced.

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Effective Date
Published Date
2/28/2025
3/6/2025

Department and Agencies

Department
Independent Agency
Agency
Executive Office of the President
Office of National Drug Control Policy
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register